Abstract

We report a case of life-threatening asthma associated with profound hypercapnia and acidosis that was refractory to conventional medical therapy but was managed successfully using an extracorporeal carbon dioxide removal (ECCO2R) device (NovaLung iLA®). In the UK, ECCO2R is still not widely available, with few intensivists and anaesthetists having experience of its use in routine intensive care unit practice. Extracorporeal CO2 removal may have a role in the management of acute life-threatening asthma and in preventing patient death and improving overall outcomes.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call